OMAHA, Neb. – Amber Specialty Pharmacy and Hy-Vee Pharmacy Solutions announced Wednesday that they are now dispensing Tezspire (tezepelumab), the first biologic to significantly reduce exacerbations in broad populations of patients with severe, uncontrolled asthma. Tezspire is a collaborative product, developed and manufactured by Amgen and AstraZeneca. Asthma is a complex and heterogeneous disease affecting
OMAHA, Neb. – Amber Specialty Pharmacy and Hy-Vee Pharmacy Solutions announce today their available services for GlaxoSmithKline’s infused medication sotrovimab. Sotrovimab is a monoclonal antibody treatment that has received the FDA’s emergency use authorization, or EUA, for the treatment of mild to moderate COVID-19 in adults and pediatric patients. Sotrovimab is authorized to treat patients (12
OMAHA, Neb. – Amber Specialty Pharmacy and Hy-Vee Pharmacy Solutions announce the launch of a COVID-19 response specifically to assist hospitals and physicians throughout the U.S. with dispensing and coordinating administration of Regeneron Monoclonal Antibody Treatment to eligible patients. According to the U.S. Food & Drug Administration (FDA), Regeneron has proven to reduce viral levels and improve symptoms
